Sign-up for Kamada Announces Positive Interim Results from Phase I/II Clinical Study of its Human Alpha-1 Antitrypsin to Treat Graft-versus-Host Disease Presented at the American Society of Hematology Annual Meeting investment picks
plc (NASDAQ: ALKS) today announced the initiation of a phase 1
clinical study of extended dosing intervals of aripiprazole lauroxil,
the company’s investigational, novel, long-acting injectable atypical
antipsychotic for the treatment of schizophrenia.
Orthofix International N.V., (NASDAQ:OFIX), today announced the
Company’s first large-scale clinical study to evaluate the use of pulsed
electromagnetic fields (PEMF) technology to see if the therapy can
improve osteogenesis (bone growth) in Type II odontoid fractures.
Results of two clinical studies of the LuViva® Advanced Cervical Scan
showed the versatility of the technology in its ability to screen the
general population for cervical cancer and to eliminate unnecessary
testing for women who are screened by other methods.
NEWARK, CA--(Marketwired - January 12, 2015) - CymaBay Therapeutics Inc. (NASDAQ: CBAY) today announced positive preliminary results from its clinical study of arhalofenate administered in combination with febuxostat (Uloric™, Takeda Pharmaceutical Company Limited). Arhalofenate is a once-daily, oral candidate for the treatment of gout with a unique dual mechanism of action which lowers serum uric acid (sUA) while also reducing the occurrence of gout flares.
Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that dosing has
begun in a Phase IIa clinical study evaluating whether its
investigational guanylate cyclase-C (GC-C) agonist, IW-9179, can provide
symptomatic relief to patients with diabetic gastroparesis.
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company,
today announced the first patient enrollment in the STAR-VT ( S ubstrate
T argeted A blation using the FlexAbility™ Ablation Catheter
System for the R eduction of V entricular T achycardia)
clinical trial, a prospective, multi-center, randomized study evaluating
the safety and efficacy of the FlexAbility™ ablation catheter when used
in ventricular tachycardia (VT) ablation procedures.
Sign-up for Clinical Study Results Presented at the 2015 Gastrointestinal Cancer Symposium Support Utility of Trovagene's Precision Cancer Monitoring Platform in Colorectal and Pancreatic Cancer Patients investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.